AbCellera Biologics Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
AbCellera Biologics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q4 2024.
  • AbCellera Biologics Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$72.8M, a 10.1% decline year-over-year.
  • AbCellera Biologics Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$315M, a 32.7% decline year-over-year.
  • AbCellera Biologics Inc. annual Operating Income (Loss) for 2024 was -$315M, a 32.7% decline from 2023.
  • AbCellera Biologics Inc. annual Operating Income (Loss) for 2023 was -$237M, a 210% decline from 2022.
  • AbCellera Biologics Inc. annual Operating Income (Loss) for 2022 was $217M, a 5.92% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$315M -$72.8M -$6.7M -10.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$308M -$93.7M -$38.8M -70.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$269M -$93.5M -$42.1M -81.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$227M -$54.9M +$9.98M +15.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$237M -$66.1M -$28.3M -74.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$209M -$54.9M -$92.6M -245% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$116M -$51.4M -$43M -512% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$73.3M -$64.9M -$290M -129% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $217M -$37.8M -$119M -146% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $336M $37.7M +$65.8M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $270M -$8.4M -$1.36M -19.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $271M $225M +$66.9M +42.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $204M $81.5M -$79.3M -49.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $284M -$28.1M -$26.3M -1489% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $310M -$7.03M -$6.18M -724% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $316M $158M +$160M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $156M $161M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 -$1.77M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$854K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$2.12M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.